Pesonalised risk prediction for severe treatment-related gastrointestinal toxicity in paediatric cancer patients using pre-treatment gut microbiome analysis [ 2018 - ]

Research Grant

Researchers: Dr Hannah Wardill (Principal investigator)

Brief description The gut is home to trillions of good and bad bacteria, critical to human health. Each person has a different balance of bacteria, unique to their gut, which shapes their immune system and susceptibility to disease. I will investigate how the unique gut bacteria, in children with blood cancer, can be used to predict which children will develop severe gut side effects (diarrhoea) from their chemotherapy. This will identify high-risk children, enable personalised treatment and improve survival.

Funding Amount $408,768.00

Funding Scheme Early Career Fellowships

Notes CJ Martin Biomedical ECF